STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake

High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.
Have a take on this story? Discuss it on Gab — no account needed to read, free to join to post.
Discuss on GabWant a second read? Ask Gab AI to analyze this story — private, no account needed to start.
Ask Gab AI💡 AI analysis provides alternative perspectives on current events